1. Henry has no plans to negotiate anything regarding warrants. He is sure on this.
2.There undisclosed information regarding "Deal's" in process. I look for disclosure on those items shorly as they are now part of a public record.
3.The Judge is questioning the need for any action. But he is going to let the Plaintiff and Defendant stew on it until August. He asked them to man up and settle or go to arbitration. In that regard I think he was supporting XXII.
4.Henry is dead set not to give up anything.
Ok..so why the need to register something just registered? Recent. ? I thought they already had filed? Did they change the language of the offering of warrants.?
Ok so I understand the need to re-register warrants nearing expiration. But I do have a question if the $10.00 warrants were repriced? Not clear on that?
Wonder if the the table is being set by FDA for rapid approval. CNBC pro article on PM being positioned to profit from alternative combustible smoking products into the future. Honestly with 76M shares outstnding what is XXII worth to the mega tobacco co's? Suppose XXII sells the Tobacco part and solley focus's on hemp and cannabis ..would be one heck of a well funded group. ??
John Chau is the contact. I can't communicate his email or phone. He is with Epiq systems. You can call NUOT and contact investor relations option 4 to get the info. He got right back to via e-mail.
What is the name and phone number for the company processing release doc's? My wife got her confirmation. Mine was mailed June 1st and I have not received confirmation. I am in South America for a while..Thanks.
Yes agreed. I would look for much more. I would expect the EU nations rolling right along for new distribution the remainder of the year. GLTA
With 1 more conversion you will see a new higher high and a new higher low channel..MHO. I still think $12.00 for new lower low and $15.00 for new higher high..near term. GLTA.....oh and then one morning you find out someone bought you for $35.00....:-).
Why would he do that..only if his chief science officer and others see value. It is obvious to me that the current study will become a new offering of SOC. After that certainly the company will want to continue to move forward and develop new better treatment. If there is some IP they think they need and they can get it right why not?? I am going to trust the scientist in this regard.
Perhaps aquisition of intellectual property once the current study is locked up. Then with a higher share price NVIV could sell some shares and go that way. I would imagine thats already on the table.
Thrope..bigot and jackwagon..take your Japanese GB dividends to the bank and thank them for taking your money.
Sentiment: Strong Buy